Literature DB >> 20640283

[The profile of antimicrobial utilization in a private hospital].

Fernanda d'Athayde Rodrigues1, Andréa Dâmaso Bertoldi.   

Abstract

The antimicrobials are one of the groups of the most prescribed drugs in hospitals and which cause a great concern for the suitability of their use. The profile of the antimicrobials utilized in a private hospital in the countryside of Rio Grande do Sul State was described and the quantity of each antimicrobial consumed was analyzed. All the prescriptions of patients who utilized antimicrobials while they were hospitalized in the period from March to June 2006 were analyzed. The antimicrobial consumption was expressed in Defined Daily Dose (DDD) in 100 day-beds. The antimicrobial utilization analysis were done generally speaking and divided by age groups and by medical clinics. During the studying period the antimicrobial use prevalence was of 52.4 % (IC 95 % 49.2 - 55.7). The cephalosporins were the most utilized (43.4 %), followed by the penicillins (16.3 %), fluoroquinolones (13.0 %) and aminoglycosides (9.7 %). The high consumption of antimicrobials during the studying period is the result of the absence of a policy for controlling the drugs prescribed in hospital and the lack of protocols of antimicrobial use. In order to exist a control of antimicrobial consumption the hospitals must assume a surveillance policy on the prescriptions of this drug group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640283     DOI: 10.1590/s1413-81232010000700033

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  Adverse events caused by potential drug-drug interactions in an intensive care unit of a teaching hospital.

Authors:  Mariana Macedo Alvim; Lidiane Ayres da Silva; Isabel Cristina Gonçalves Leite; Marcelo Silva Silvério
Journal:  Rev Bras Ter Intensiva       Date:  2015 Oct-Dec

2.  Data Sources for Drug Utilization Research in Brazil-DUR-BRA Study.

Authors:  Lisiane Freitas Leal; Claudia Garcia Serpa Osorio-de-Castro; Luiz Júpiter Carneiro de Souza; Felipe Ferre; Daniel Marques Mota; Marcia Ito; Monique Elseviers; Elisangela da Costa Lima; Ivan Ricardo Zimmernan; Izabela Fulone; Monica Da Luz Carvalho-Soares; Luciane Cruz Lopes
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.